Annual EBIT
-$11.37 M
+$6.88 M+37.70%
31 March 2024
Summary:
Acasti Pharma annual earnings before interest & taxes is currently -$11.37 million, with the most recent change of +$6.88 million (+37.70%) on 31 March 2024. During the last 3 years, it has fallen by -$651.00 thousand (-6.08%). ACST annual EBIT is now -638.93% below its all-time high of -$1.53 million.ACST EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$4.83 M
+$132.00 K+2.66%
30 September 2024
Summary:
Acasti Pharma quarterly earnings before interest & taxes is currently -$4.83 million, with the most recent change of +$132.00 thousand (+2.66%) on 30 September 2024. Over the past year, it has dropped by -$1.79 million (-58.76%). ACST quarterly EBIT is now -128.97% below its all-time high of $16.67 million, reached on 31 March 2020.ACST Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$16.10 M
-$2.74 M-20.50%
30 September 2024
Summary:
Acasti Pharma TTM earnings before interest & taxes is currently -$16.10 million, with the most recent change of -$2.74 million (-20.50%) on 30 September 2024. Over the past year, it has dropped by -$3.83 million (-31.23%). ACST TTM EBIT is now -305.25% below its all-time high of $7.84 million, reached on 31 December 2020.ACST TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACST EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +37.7% | -58.8% | -31.2% |
| 3 y3 years | -6.1% | -14.3% | -25.6% |
| 5 y5 years | +70.9% | +60.0% | +71.1% |
ACST EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -6.1% | +37.7% | -130.9% | +5.4% | -41.6% | +12.9% |
| 5 y | 5 years | -6.1% | +70.9% | -129.0% | +60.0% | -305.3% | +71.1% |
| alltime | all time | -638.9% | +70.9% | -129.0% | +77.1% | -305.3% | +71.1% |
Acasti Pharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.83 M(-2.7%) | -$16.10 M(+20.5%) |
| June 2024 | - | -$4.96 M(+52.1%) | -$13.36 M(+17.5%) |
| Mar 2024 | -$11.37 M(-37.7%) | -$3.26 M(+7.2%) | -$11.37 M(-7.4%) |
| Dec 2023 | - | -$3.04 M(+45.5%) | -$12.27 M(-8.9%) |
| Sept 2023 | - | -$2.09 M(-29.5%) | -$13.47 M(-18.3%) |
| June 2023 | - | -$2.97 M(-28.7%) | -$16.49 M(-9.7%) |
| Mar 2023 | -$18.25 M(+19.0%) | -$4.17 M(-1.9%) | -$18.25 M(-1.3%) |
| Dec 2022 | - | -$4.25 M(-16.9%) | -$18.49 M(+0.1%) |
| Sept 2022 | - | -$5.11 M(+8.0%) | -$18.47 M(+9.1%) |
| June 2022 | - | -$4.73 M(+7.4%) | -$16.93 M(+10.3%) |
| Mar 2022 | -$15.34 M(+43.2%) | -$4.40 M(+4.2%) | -$15.34 M(+19.6%) |
| Dec 2021 | - | -$4.22 M(+18.4%) | -$12.82 M(+21.4%) |
| Sept 2021 | - | -$3.57 M(+13.4%) | -$10.56 M(+8.4%) |
| June 2021 | - | -$3.15 M(+66.7%) | -$9.74 M(-9.1%) |
| Mar 2021 | -$10.72 M(-57.6%) | -$1.89 M(-3.9%) | -$10.72 M(-236.6%) |
| Dec 2020 | - | -$1.96 M(-28.4%) | $7.84 M(-446.8%) |
| Sept 2020 | - | -$2.74 M(-33.4%) | -$2.26 M(-89.0%) |
| June 2020 | - | -$4.12 M(-124.7%) | -$20.61 M(-18.4%) |
| Mar 2020 | -$25.27 M(-35.4%) | $16.67 M(-238.1%) | -$25.26 M(-54.6%) |
| Dec 2019 | - | -$12.07 M(-42.8%) | -$55.71 M(+18.6%) |
| Sept 2019 | - | -$21.09 M(+140.2%) | -$46.95 M(+8.2%) |
| June 2019 | - | -$8.78 M(-36.2%) | -$43.39 M(+8.0%) |
| Mar 2019 | -$39.09 M(+138.8%) | -$13.77 M(+315.1%) | -$40.18 M(+24.1%) |
| Dec 2018 | - | -$3.32 M(-81.1%) | -$32.37 M(-4.3%) |
| Sept 2018 | - | -$17.52 M(+214.4%) | -$33.82 M(+70.3%) |
| June 2018 | - | -$5.57 M(-6.5%) | -$19.85 M(+21.5%) |
| Mar 2018 | -$16.37 M(+92.5%) | -$5.96 M(+25.2%) | -$16.35 M(+57.4%) |
| Dec 2017 | - | -$4.76 M(+33.8%) | -$10.39 M(+40.2%) |
| Sept 2017 | - | -$3.56 M(+72.3%) | -$7.41 M(+31.6%) |
| June 2017 | - | -$2.07 M(+15.8%) | -$5.63 M(-21.9%) |
| Mar 2017 | -$8.50 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2016 | - | -$1.78 M(+0.3%) | -$7.21 M(+2.1%) |
| Aug 2016 | - | -$1.78 M(-21.6%) | -$7.06 M(+13.6%) |
| May 2016 | - | -$2.27 M(+65.0%) | -$6.22 M(+31.6%) |
| Feb 2016 | -$4.66 M(-52.9%) | -$1.38 M(-16.1%) | -$4.73 M(-65.8%) |
| Nov 2015 | - | -$1.64 M(+75.0%) | -$13.83 M(+44.6%) |
| Aug 2015 | - | -$936.10 K(+20.6%) | -$9.56 M(-20.6%) |
| May 2015 | - | -$776.30 K(-92.6%) | -$12.04 M(+20.2%) |
| Feb 2015 | -$9.91 M(-5.1%) | -$10.48 M(-498.5%) | -$10.01 M(+412.2%) |
| Nov 2014 | - | $2.63 M(-177.1%) | -$1.96 M(-74.6%) |
| Aug 2014 | - | -$3.41 M(-372.9%) | -$7.70 M(+4.6%) |
| May 2014 | - | $1.25 M(-151.6%) | -$7.36 M(-30.0%) |
| Feb 2014 | -$10.44 M(+55.1%) | -$2.42 M(-22.2%) | -$10.51 M(+6.7%) |
| Nov 2013 | - | -$3.11 M(+1.3%) | -$9.85 M(+17.8%) |
| Aug 2013 | - | -$3.07 M(+61.1%) | -$8.36 M(+18.5%) |
| May 2013 | - | -$1.91 M(+8.3%) | -$7.05 M(+5.7%) |
| Feb 2013 | -$6.73 M(+3.1%) | -$1.76 M(+8.5%) | -$6.67 M(+0.3%) |
| Nov 2012 | - | -$1.62 M(-8.1%) | -$6.65 M(-7.2%) |
| Aug 2012 | - | -$1.76 M(+15.4%) | -$7.17 M(+0.1%) |
| May 2012 | - | -$1.53 M(-12.0%) | -$7.16 M(+7.2%) |
| Feb 2012 | -$6.53 M(+112.4%) | -$1.74 M(-18.7%) | -$6.68 M(+10.5%) |
| Nov 2011 | - | -$2.14 M(+21.6%) | -$6.04 M(+29.1%) |
| Aug 2011 | - | -$1.76 M(+67.7%) | -$4.68 M(+31.2%) |
| May 2011 | - | -$1.05 M(-5.2%) | -$3.57 M(+17.8%) |
| Feb 2011 | -$3.07 M(+99.9%) | -$1.10 M(+43.0%) | -$3.03 M(+29.2%) |
| Nov 2010 | - | -$772.20 K(+20.0%) | -$2.34 M(+20.2%) |
| Aug 2010 | - | -$643.60 K(+26.5%) | -$1.95 M(+10.9%) |
| May 2010 | - | -$508.70 K(+21.2%) | -$1.76 M(+16.1%) |
| Feb 2010 | -$1.54 M | -$419.80 K(+10.9%) | -$1.51 M(+38.4%) |
| Nov 2009 | - | -$378.60 K(-16.1%) | -$1.09 M(+21.0%) |
| Aug 2009 | - | -$451.30 K(+70.6%) | -$904.40 K(+99.6%) |
| May 2009 | - | -$264.50 K(+40.2%) | -$453.10 K(+140.2%) |
| Nov 2008 | - | -$188.60 K | -$188.60 K |
FAQ
- What is Acasti Pharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Acasti Pharma?
- What is Acasti Pharma annual EBIT year-on-year change?
- What is Acasti Pharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Acasti Pharma?
- What is Acasti Pharma quarterly EBIT year-on-year change?
- What is Acasti Pharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Acasti Pharma?
- What is Acasti Pharma TTM EBIT year-on-year change?
What is Acasti Pharma annual earnings before interest & taxes?
The current annual EBIT of ACST is -$11.37 M
What is the all time high annual EBIT for Acasti Pharma?
Acasti Pharma all-time high annual earnings before interest & taxes is -$1.53 M
What is Acasti Pharma annual EBIT year-on-year change?
Over the past year, ACST annual earnings before interest & taxes has changed by +$6.88 M (+37.70%)
What is Acasti Pharma quarterly earnings before interest & taxes?
The current quarterly EBIT of ACST is -$4.83 M
What is the all time high quarterly EBIT for Acasti Pharma?
Acasti Pharma all-time high quarterly earnings before interest & taxes is $16.67 M
What is Acasti Pharma quarterly EBIT year-on-year change?
Over the past year, ACST quarterly earnings before interest & taxes has changed by -$1.79 M (-58.76%)
What is Acasti Pharma TTM earnings before interest & taxes?
The current TTM EBIT of ACST is -$16.10 M
What is the all time high TTM EBIT for Acasti Pharma?
Acasti Pharma all-time high TTM earnings before interest & taxes is $7.84 M
What is Acasti Pharma TTM EBIT year-on-year change?
Over the past year, ACST TTM earnings before interest & taxes has changed by -$3.83 M (-31.23%)